The Cooper Companies, Inc. (COO)

NASDAQ · Health Care · market cap 11.94B

Share price

$53.77

At the last nightly close

Intrinsic value

$43.35

A single conservative estimate.

Margin of safety

-19.4%

($43.35 − $53.77) ÷ $53.77

EV / EBIT

32.6

On the median operating profit of 15 fiscal years through 2025.

How these numbers are computed

The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above is the low end of what they agree on.

The frame gives no credit for growth. A company that compounds will therefore read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.

The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.

Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-09-13.

Key metrics

Price / earnings18.5
Price / book1.2
EV / EBITDA14.0
FCF / EV+2.2%
Return on equity+6.8%
Return on assets+2.7%
Debt / equity0.34
Gross margin+65.9%

Market position

52-week high$84.32
52-week low$53.27
From 52-week high-36.2%
RSI (14)19.6
200-day moving average$70.11

Annual financials

PeriodRevenueOperating incomeNet incomeEPSFree cash flow
2025-FY4.09B682.9M374.9M1.88433.7M
2024-FY3.90B705.7M392.3M1.97288.1M
2023-FY3.59B533.1M294.2M1.49215.0M
2022-FY3.31B507.6M385.8M1.96450.4M
2021-FY2.92B505.8M2.94B59.16524.2M

Filed figures from SEC EDGAR, in the reporting currency.

Next earnings

Q4 2026 expectedDecember 10, 2026
Consensus EPS estimate1.07

Recent news

The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on COO.

Run the board on COO

10 free analyses · no signup, no card

This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.